(US20160082005) In its several embodiments, this invention discloses a pharmaceutical formulation comprising at least one antineoplastic agent or a pharmaceutically acceptable salt thereof, and at least one dissolution enhancing agent sufficient to substantially dissolve said at least one antineoplastic agent in at least one aqueous diluent, wherein said dissolution enhancing agent is urea, L-histidine, L-threonine, L-asparagine, L-serine, L-glutamine or mixtures thereof; a lyophilized powder comprising said pharmaceutical formulation, and articles of manufacture thereof.
(US20160082005) 1. A process of making a pharmaceutical formulation comprising the steps of: (i) dissolving at least one dissolution enhancing agent in at least one aqueous diluent wherein said dissolution enhancing agent is selected from the group consis
(US20160082005) LEGAL DETAILS FOR US2016082005 Actual or expected expiration date=2023-02-21 Legal state=ALIVE Status=PENDING Event publication date=2015-12-03 Event code=US/APP Event indicator=Pos Event type=Examination events Application details Application country=US US14957653 Application date=2015-12-03 Standardized application number=2015US-14957653 Event publication date=2015-12-03 Event code=US/EXMR Event type=Administrative notifications USPTO Examiner Name Primary Examiner: RODRIGUEZ, RAYNA B Event publication date=2015-12-03 Event code=US/ART Event type=Administrative notifications USPTO Art Group ART=1628 Event publication date=2015-12-03 Event code=US/DK Event type=Examination events Attorney Docket Number Docket Nbr: PD01553-US-CNT-4 Customer Nbr: 210 Event publication date=2015-12-03 Event code=US/ENT Event type=Administrative notifications Business Entity Status: UNDISCOUNTED Event publication date=2015-12-03 Event code=US/AIA Event type=Administrative notifications First Inventor File Indicated: AIA=No Event publication date=2015-12-03 Event code=US/PTARDY Event indicator=Pos Event type=Examination events Patent Term Adjustment - Ready for Examination Event publication date=2015-12-03 Event code=US/ENTYSTA Event type=Administrative notifications Entity Status Set to Undiscounted Event publication date=2015-12-15 Event code=US/APPFILEREC Event type=Administrative notifications Event type=OAO Filing Receipt Event publication date=2016-01-26 Event code=US/DOCK Event indicator=Pos Event type=Examination events Case Docketed to Examiner in GAU Event publication date=2016-03-04 Event code=US/IDS Event type=Examination events Event type=OAI Information Disclosure Statement Filed Event publication date=2016-03-24 Event code=US/A1 Event type=Examination events Application published Publication country=US Publication number=US2016082005 Publication stage Code=A1 Publication date=2016-03-24 Standardized publication number=US20160082005 Event publication date=2016-03-24 Event code=US/PGPUBN Event indicator=Pos Event type=Examination events Event type=OAO PG-Pub Issue Notification Event publication date=2016-05-06 Event code=US/RECEIPTCOR Event type=Administrative notifications Event type=OAO Filing Receipt - Corrected Event publication date=2016-05-25 Event code=US/DOCK Event indicator=Pos Event type=Examination events Case Docketed to Examiner in GAU Event publication date=2016-07-18 Event code=US/DOCK Event indicator=Pos Event type=Examination events Case Docketed to Examiner in GAU Event publication date=2017-04-06 Event code=US/DOCK Event indicator=Pos Event type=Examination events Case Docketed to Examiner in GAU Event publication date=2017-06-22 Event code=US/CTNF Event type=Examination events Event type=OA Event type=OAO Non-Final Rejection
最新评论
暂无评论。